Andrey Soares
About
Andrey Soares is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery.
According to data from OpenAlex, Andrey Soares has authored 36 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 16 papers in Oncology and 15 papers in Surgery. Recurrent topics in Andrey Soares's work include Prostate Cancer Treatment and Research (12 papers), Cancer Immunotherapy and Biomarkers (11 papers) and Renal cell carcinoma treatment (9 papers). Andrey Soares is often cited by papers focused on Prostate Cancer Treatment and Research (12 papers), Cancer Immunotherapy and Biomarkers (11 papers) and Renal cell carcinoma treatment (9 papers). Andrey Soares collaborates with scholars based in Brazil, United States and Spain. Andrey Soares's co-authors include Fernando Sabino Marques Monteiro, Enrique Grande, Matteo Santoni, Francesco Massari, Veronica Mollica, Alessandro Rizzo, Nicola Battelli, Jakub Kucharz, Javier Molina‐Cerrillo and Andrea Marchetti and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.
In The Last Decade
Andrey Soares
30 papers receiving 315 citations
Hit Papers
Peers
Andrey Soares
Shinya Maita Japan
Shota Fujimoto Japan
Ondřej Kubeček Czechia
Xiao Shi China
Xi Jiao China
Tuğba Akın Telli Türkiye
Xiao Lin China
Rania Chehade Canada
Wenyong Sun China
Zhangheng Huang China
Citations per year, relative to Andrey Soares Andrey Soares (= 1×)
peers
Shinya Maita
Countries citing papers authored by Andrey Soares
Since
Specialization
Citations
This map shows the geographic impact of Andrey Soares's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrey Soares with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrey Soares more than expected).
Fields of papers citing papers by Andrey Soares
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Andrey Soares. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrey Soares. The network helps show where Andrey Soares may publish in the future.
Co-authorship network of co-authors of Andrey Soares
This figure shows the co-authorship network connecting the top 25 collaborators of Andrey Soares. A scholar is included among the top collaborators of Andrey Soares based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrey Soares. Andrey Soares is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Monteiro, Fernando Sabino Marques, Andrey Soares, Veronica Mollica, et al.. (2024). Efficacy of immune checkpoint inhibitors combinations as first-line systemic treatment in patients with advanced urothelial carcinoma: A systematic review and network meta-analysis. Critical Reviews in Oncology/Hematology. 196. 104321–104321.
2.
Monteiro, Fernando Sabino Marques, Denizar Vianna Araújo, Rana R. McKay, et al.. (2024). Surgical Castration as an Alternative to Improve Systemic Treatment for Advanced Prostate Cancer: A Window of Opportunity for Developing Countries. JCO Global Oncology. 10(10). e2400319–e2400319.
3.
Agarwal, Neeraj, Arun Azad, Joan Carles, et al.. (2024). CONTACT-02: Phase 3 study of cabozantinib (C) plus atezolizumab (A) vs second novel hormonal therapy (NHT) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 42(4_suppl). 18–18.
4.
Monteiro, Fernando Sabino Marques, Veronica Mollica, Oronzo Brunetti, et al.. (2024). Metastatic sites and clinical outcomes in renal cell carcinoma patients receiving immune-based combinations: the MOUSEION-08 study. Clinical & Experimental Metastasis. 42(1). 9–9.
5.
Shore, Neal D., Michael S. Broder, Pedro C. Barata, et al.. (2024). Expert Consensus Recommendations on the Management of Treatment-emergent Adverse Events Among Men with Prostate Cancer Taking Poly-ADP Ribose Polymerase Inhibitor + Novel Hormonal Therapy Combination Therapy. European Urology Oncology. 8(1). 94–104.
6.
Soares, Andrey, et al.. (2024). Differential diagnosis of visceral leishmaniasis in children: a five-year retrospective study at a pediatric referral hospital. BMC Pediatrics. 24(1). 726–726.
7.
Agarwal, Neeraj, Arun Azad, Stéphane Oudard, et al.. (2024). LBA67 Cabozantinib (C) plus atezolizumab (A) versus 2nd novel hormonal therapy (NHT) in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC): Final overall survival (OS) results of the phase III, randomized, CONTACT-02 study. Annals of Oncology. 35. S1256–S1257.
8.
Soares, Andrey, et al.. (2024). INTELIGÊNCIA ARTIFICIAL E ROBÓTICA: IMPORTÂNCIA, DIFICULDADES E IMPLICAÇÕES NA ASSISTÊNCIA À SAÚDE. Revista fisio&terapia.. 29(140). 56–57.
9.
Soares, Andrey, María T. Bourlon, Alvin Wong, et al.. (2024). Management of Metastatic Urothelial Carcinoma in Emerging Markets (EM): An Expert Opinion. Clinical Genitourinary Cancer. 22(2). 467–475.
10.
Monteiro, Fernando Sabino Marques, Veronica Mollica, Andrey Soares, et al.. (2024). Impact of time-of-day administration of immunotherapy on survival in metastatic renal cell carcinoma: the MOUSEION-09 meta-analysis. Clinical & Experimental Metastasis. 42(1). 3–3.
11.
Monteiro, Fernando Sabino Marques, Andrey Soares, Alessandro Rizzo, et al.. (2023). The role of immune checkpoint inhibitors (ICI) as adjuvant treatment in renal cell carcinoma (RCC): A systematic review and meta-analysis. Clinical Genitourinary Cancer. 21(3). 324–333.
12.
Santoni, Matteo, Alessandro Rizzo, Jakub Kucharz, et al.. (2023). Complete remissions following immunotherapy or immuno-oncology combinations in cancer patients: the MOUSEION-03 meta-analysis. Cancer Immunology Immunotherapy. 72(6). 1365–1379.
13.
Agarwal, Neeraj, Arun Azad, Joan Carles, et al.. (2022). A Phase III, Randomized, Open-Label Study (CONTACT-02) of Cabozantinib Plus Atezolizumab Versus Second Novel Hormone Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer. Future Oncology. 18(10). 1185–1198.
14.
Dettino, Aldo Lourenço Abbade, Ariel Galapo Kann, Carlos Dzik, et al.. (2021). Consensus on the Treatment and Follow-Up for the Nonmetastatic Castration-Resistant Prostate Cancer: A Report From the First Prostate Cancer Consensus Conference for Developing Countries. JCO Global Oncology. 7(7). 545–549.
15.
Monteiro, Fernando Sabino Marques, Fabio A. Schutz, Diogo Assed Bastos, et al.. (2021). Consensus on Treatment and Follow-Up for Biochemical Recurrence in Castration-Sensitive Prostate Cancer: A Report From the First Global Prostate Cancer Consensus Conference for Developing Countries. JCO Global Oncology. 7(7). 538–544.
16.
Soares, Andrey, Fabio A.B. Schutz, Diogo Assed Bastos, Denis L. Jardim, & Fernando Sabino Marques Monteiro. (2020). Use of Immunotherapy in Patients With Cancer During the COVID-19 Pandemic. PubMed. 34(3409). 370–373.
17.
Monteiro, Fernando Sabino Marques, Andrey Soares, Márcio Debiasi, et al.. (2020). First-line Treatment of Metastatic Renal Cell Carcinoma in the Immuno-oncology Era: Systematic Review and Network Meta-analysis. Clinical Genitourinary Cancer. 18(4). 244–251.e4.
18.
Soares, Andrey, et al.. (2019). Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma: How to Apply New Evidence in Clinical Practice. Oncology. 98(1). 1–9.
19.
Soares, Andrey, et al.. (2013). Copper, nickel and zinc removal by peanut hulls: batch and column studies in mono, tri-component systems and with real effluent. Global NEST Journal. 12(2). 206–214.
20.
Soares, Andrey, et al.. (2012). Fatal Pneumonitis Induced by Oxaliplatin: Description of Three Cases. Case Reports in Oncology. 5(1). 104–109.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Shinya Maita Breakdown of academic impact, for papers by Shota Fujimoto Breakdown of academic impact, for papers by Ondřej Kubeček Breakdown of academic impact, for papers by Xiao Shi Breakdown of academic impact, for papers by Xi Jiao Breakdown of academic impact, for papers by Tuğba Akın Telli Breakdown of academic impact, for papers by Xiao Lin Breakdown of academic impact, for papers by Rania Chehade Breakdown of academic impact, for papers by Wenyong Sun Breakdown of academic impact, for papers by Zhangheng Huang